Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Boeckh

Showing results (11-20 of 331) with videos related to

Pageof 34
Sort By:
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Herpes : the Journal of the IHMF|May 17, 2003
Immunosuppressive effects of beta-herpesvirusesMichael Boeckh, W Garrett Nichols
Blood|December 3, 2003
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapyMichael Boeckh, W Garrett Nichols
American Journal of Respiratory and Critical Care Medicine|November 17, 2010
Evaluation of therapeutics for RSV: an important step forwardMichael Boeckh, Janet A Englund
Current Opinion in Virology|March 24, 2012
Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?Francisco M Marty, Michael Boeckh
The Journal of Clinical Investigation|June 11, 2011
Cytomegalovirus: pathogen, paradigm, and puzzleMichael Boeckh, Adam P Geballe
Reviews in Medical Virology|October 9, 2010
CMV in critically ill patients: pathogen or bystander?Ajit P Limaye, Michael Boeckh
The Journal of Infectious Diseases|January 31, 2007
Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?Michael Boeckh, Stanley R Riddell
Current Opinion in Infectious Diseases|July 18, 2022
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infectionsJim Boonyaratanakornkit, Michael Boeckh, Alpana Waghmare
Blood|December 17, 2009
How I treat influenza in patients with hematologic malignanciesCorey Casper, Janet Englund, Michael Boeckh
Pageof 34

Showing results (11-20 of 331) with videos related to

Sort By:
Pageof 34
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Herpes : the Journal of the IHMF|May 17, 2003
Immunosuppressive effects of beta-herpesvirusesMichael Boeckh, W Garrett Nichols
Blood|December 3, 2003
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapyMichael Boeckh, W Garrett Nichols
American Journal of Respiratory and Critical Care Medicine|November 17, 2010
Evaluation of therapeutics for RSV: an important step forwardMichael Boeckh, Janet A Englund
Current Opinion in Virology|March 24, 2012
Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?Francisco M Marty, Michael Boeckh
The Journal of Clinical Investigation|June 11, 2011
Cytomegalovirus: pathogen, paradigm, and puzzleMichael Boeckh, Adam P Geballe
Reviews in Medical Virology|October 9, 2010
CMV in critically ill patients: pathogen or bystander?Ajit P Limaye, Michael Boeckh
The Journal of Infectious Diseases|January 31, 2007
Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?Michael Boeckh, Stanley R Riddell
Current Opinion in Infectious Diseases|July 18, 2022
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infectionsJim Boonyaratanakornkit, Michael Boeckh, Alpana Waghmare
Blood|December 17, 2009
How I treat influenza in patients with hematologic malignanciesCorey Casper, Janet Englund, Michael Boeckh
Pageof 34